EMISPHERE TECHNOLOGIES INC
DelistedCIK 805326fmd_1458TX0QF7MDB09QDBHT5W5AY5Manufacturing · Pharmaceutical PreparationsTemplate: Standard
Coverage: Jan 01, 2009 to Mar 31, 2017, 29 periods
| Line item | FY2009 | FY2010 | FY2011 | FY2012 | FY2013 | FY2014 | FY2015 | FY2016 |
|---|---|---|---|---|---|---|---|---|
| Total revenues | 0 | 0 | – | 0 | 0 | 0 | 0 | 1 |
| Cost of revenue | 0 | 0 | – | 0 | 0 | 0 | 0 | 0 |
| Gross profit | 0 | 0 | – | 0 | 0 | 0 | (0) | (0) |
| Real estate taxes | – | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Research and development | 4 | 2 | 2 | 2 | 1 | 1 | 0 | 0 |
| Selling, general and administrative | – | – | – | – | – | 8 | 17 | 7 |
| Total operating expenses | – | – | – | – | 8 | 9 | 18 | 8 |
| Operating income | (15) | (12) | (8) | (7) | (8) | (9) | (18) | (8) |
| Interest expense | – | – | – | – | – | – | – | 0 |
| Other non-operating income (expense) | – | (45) | 23 | 2 | (13) | (18) | (23) | (2) |
| Income before taxes | – | (57) | 15 | (5) | (21) | (27) | (41) | (10) |
| Income tax expense | – | – | – | (3) | 0 | (2) | (1) | – |
| Net income from continuing operations | – | – | – | (2) | (21) | (25) | (40) | – |
| Net income | (17) | (57) | 15 | (2) | (21) | (25) | (40) | (10) |